Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Professionals

    Resources Health care providers are the primary source of information for their patients, but they too need access to factual and...

    Page last updated 05/03/2018 - 2:28pm.

  2. Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine

    ... and decitabine are standard therapy for myelodysplastic syndromes (MDS), and are often used to treat patients with acute myeloid ...

    Research Article last updated 10/02/2014 - 10:13am.

  3. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study

    ... Myelodysplastic syndromes (MDS) often transform into acute leukemia (AL-MDS), although its ...

    Research Article last updated 04/02/2013 - 7:59am.

  4. The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes

    ... Myelodysplastic syndromes (MDS) are a heterogeneous cluster of clonal hematopoietic ...

    Research Article last updated 01/20/2015 - 1:08pm.

  5. Costs and quality of life in patients with myelodysplastic syndromes.

    ... Myelodysplastic syndromes (MDS) encompass a range of myeloid neoplasms characterised by a ...

    Research Article last updated 09/16/2013 - 8:45am.

  6. Stem and progenitor cell alterations in myelodysplastic syndromes

    ... Recent studies have demonstrated that myelodysplastic syndromes (MDS) arise from a small population of disease initiating ...

    Research Article last updated 02/21/2017 - 10:17am.

  7. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis

    ... binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic ...

    Research Article last updated 02/21/2017 - 10:33am.

  8. Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes

    ... The treatment of patients with myelodysplastic syndromes (MDS) begins with assessment of karyotype and risk. ...

    Research Article last updated 12/08/2015 - 1:06pm.

  9. Epigenetics of myelodysplastic syndromes

    ... Myelodysplastic syndromes (MDS) are clonal diseases of the elderly characterized by chronic ...

    Research Article last updated 11/26/2013 - 12:37pm.

  10. How we treat higher-risk myelodysplastic syndromes

    ... Higher-risk myelodysplastic syndromes (MDS) are defined as patients who fall into higher risk group ...

    Research Article last updated 01/08/2014 - 8:57am.